• Reckitt Benckiser Fined £10.2 Million by UK Competition Authority for Withdrawing a Product Which Faced Generic Competition
  • October 26, 2010 | Authors: Alasdair Balfour; Claire McComb
  • Law Firm: Fried, Frank, Harris, Shriver & Jacobson (London) LLP - London Office
  • Pharma giant Reckitt Benckiser was fined £10.2 million ($16.2 million) by the UK Office of Fair Trading on October 15 for abusing its dominant position by withdrawing heartburn medicine Gaviscon Original Liquid after the product's patent expired and it faced competition from generic equivalents. This decision is another example of competition authorities investigating pharma company patent strategies which they consider are designed to impede generic competition.